Noema Pharma plc (NASDAQ:NOEMW) Sees Large Drop in Short Interest

Noema Pharma plc (NASDAQ:NOEMW) was the target of a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 883 shares, a decline of 65.1% from the September 15th total of 2,531 shares. Based on an average daily trading volume, of 9,040 shares, the days-to-cover ratio is currently 0.1 days.

Noema Pharma Stock Up 19.8%

Shares of NOEMW traded up $0.02 during mid-day trading on Tuesday, reaching $0.12. The company had a trading volume of 447 shares, compared to its average volume of 20,032. Noema Pharma has a 52-week low of $0.07 and a 52-week high of $0.24. The stock has a 50 day moving average of $0.14 and a two-hundred day moving average of $0.12.

Noema Pharma is a clinical-stage biopharmaceutical company focused on developing treatments for rare neurological and neurodevelopmental disorders. The company’s research and development activities center on medicines intended to address conditions with significant unmet medical needs in the central nervous system.

Noema Pharma’s pipeline has included investigational compounds targeting neurological conditions such as fragile X syndrome and tuberous sclerosis complex. Its programs are designed to modulate biological pathways associated with abnormal brain signaling, with development stages and indications subject to change as clinical studies progress.

The company is headquartered in Switzerland and operates internationally through research, clinical development and collaborations with healthcare and biotechnology organizations.